Global cancer statistics 2022

GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Datos Bibliográficos

ID23385348
AutoresFrancesca Bray (0000-0002-3248-7787, Cancer Surveillance Branch International Agency for Research on Cancer Lyon France, autor de correspondencia), Mathieu Laversanne (0000-0002-1568-7218, Cancer Surveillance Branch International Agency for Research on Cancer Lyon France), Hyuna Sung (0000-0002-8021-5997, Surveillance and Health Equity Science American Cancer Society Atlanta Georgia USA), J Ferlay (0000-0003-4927-6932, Centre international de recherche sur le cancer), Rebecca L Siegel (0000-0001-5247-8522, Surveillance and Health Equity Science American Cancer Society Atlanta Georgia USA), Isabelle Soerjomataram (0000-0002-6017-741X, Cancer Surveillance Branch International Agency for Research on Cancer Lyon France), Ahmedin Jemal (0000-0002-0000-4111, Surveillance and Health Equity Science American Cancer Society Atlanta Georgia USA)
Año2024
Volumen74
Número3
Páginas229-263
Fecha de publicación2024-05-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaCA: A Cancer Journal for Clinicians (JOURNAL)
Identificadores de la revistaISSN: 0007-9235 • E-ISSN: 1542-4863
EditorialWiley (PUBLISHER • GB)
DOI10.3322/caac.21834
PMID38572751
OpenAlexW4393935425
IdiomaEN
Citas recibidas302
Referencias citadas169

This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four‐fold to five‐fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South‐Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics‐based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.

Breast cancer · Cancer · Cause of death · Causes of cancer · Colorectal cancer · Disease · Gynecology · Incidence (geometry) · International agency · Lung cancer · Prostate cancer · Skin cancer · Stomach cancer · Colorectal Cancer Screening and Detection · Demography · Global Cancer Incidence and Screening · Internal Medicine · Medicine · Multiple and Secondary Primary Cancers · Oncology